A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 2	2023-08-21		NCT06000917

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	4
WuhanHU	Wuhan	China	1

Clinical trials